Measles And Its Complications In Immunocompromised Individuals
Published on: February 12, 2025
measles and its complications in immunocompromised individuals
  • Article reviewer photo

    Isabelle Lally

    Bachelor of Science with Honours in Biology, University of Nottingham

Introduction

Measles is a highly infectious disease that causes symptoms such as fever, cough, runny nose, conjunctivitis, and a unique rash. Despite the effectiveness of the measles vaccine, it remains crucial that people worldwide continue to get vaccinated against measles. This is especially true now that vaccination rates are going down in some regions.

Immunocompromised people have weakened immune systems due to conditions like HIV/AIDS, cancer treatments, organ transplants, or primary immunodeficiency diseases. As a result, these people are more likely to get infections like measles, which can cause severe complications and higher rates of illness and death compared to the general population.

The goal of this article is to provide a full picture of measles and its potential complications for people with weakened immune systems. Understanding the specific problems these at-risk groups face is important for coming up with effective ways to avoid, diagnose, and treat measles, ultimately improving health outcomes and lowering the disease's impact. 

Measles: A quick overview 

How it happens

Measles is caused by a virus known as the measles virus (MeV). This virus is very infectious and spreads through coughs and sneezes. The virus can remain in the air and on surfaces for up to two hours, making it easy to transmit.

Signs and symptoms 

The first signs of measles include a cough, stuffy nose, fever, and conjunctivitis. Many people who have measles often develop Koplik spots, small white sores inside the mouth. Following these initial symptoms, a red, blotchy rash appears, starting on the face and moving down the body.

Epidemiology

Measles remains a significant health problem around the world, especially in places where not many people have been vaccinated. With the introduction of the measles vaccine, the sickness has been much less common. However, recent outbreaks have occured because vaccine rates are falling. This shows how it is important to keep vaccination rates high to stop a resurgence.

Immunocompromised individuals - definition and categories

What does "immunocompromised status" mean?

People who are immunocompromised have immune systems that aren't working as well, making them more susceptible to illness. This can happen due to many illnesses and treatments, such as HIV/AIDS, cancer treatments, organ transplants, and primary immunodeficiency diseases. The immune system can also be weakened by prolonged use of corticosteroids and other immunosuppressive drugs.

Types of immunocompromised people HIV/AIDS patients

The human immunodeficiency virus (HIV) weakens and kills immune cells, leaving people with weak immune systems.

Cancer patients receiving chemotherapy

While chemotherapy kills cancer cells, it also affects cells that divide quickly, such as immune cells, increasing the risk of infection.

Organ transplant recipients

These people take drugs that weaken their immune systems to prevent organ rejection.

People with primary immunodeficiency disorders

These are genetic diseases that directly weaken the immune system.

Measles in immunocompromised individuals

Increased susceptibility

Immunocompromised individuals are more likely to contract measles because their immune systems aren't as strong and can't fight off infections as well. As a result, they are more prone to infections and often experience worse outcomes compared to the general population.

Changes in clinical presentation

People with weakened immune systems may have strange measles signs that make diagnosis difficult. Symptoms such as the rash and Koplik spots may be absent or less noticeable. This can lead to delays in obtaining an accurate diagnosis and treatment, increasing the risk of problems.

Complications

Measles can cause serious consequences for people with weakened immune systems. They face a greater chance of developing pneumonia, encephalitis (inflammation of the brain), and subacute sclerosing panencephalitis (SSPE), a rare but fatal neurological problem that worsens over time. These problems are more frequent and severe in immunocompromised people, leading to increased illness and death. Reducing these risks is very important for the health of this vulnerable population.

Diagnosis and treatment

Diagnosis

People with weakened immune systems need both clinical evaluation and laboratory tests to be diagnosed with measles. In the clinic, doctors look for symptoms such as fever, rash, and Koplik spots. However, because immunocompromised patients often present strange symptoms, laboratory proof is necessary. Serology tests detect antibodies specific to measles, while polymerase chain reaction (PCR) tests identify viral RNA, providing an accurate diagnosis.

Treatment and management

People with weakened immune systems need a lot of care when they get measles. Supportive care, such as giving them water, painkillers, and food, is very important. Antiviral drugs, like ribavirin, can be used, but not all of them work. To deal with problems such as pneumonia and encephalitis, specific medicines are necessary, including antibiotics for secondary infections and corticosteroids for brain inflammation.

Immunocompromised patients need extra care, including closer monitoring and interventions that are specifically designed to help them. To reduce the risk of serious complications and improve outcomes in this high-risk group, treatment must start quickly and be aggressive. 

Prevention strategies

Vaccination

To avoid getting measles, individuals should get the MMR (measles, mumps, and rubella) vaccine. This vaccine significantly lowers the chances of getting sick and has helped to reduce the number of measles cases worldwide. However, it can be difficult to vaccinate people with weakened immune systems. Because their immune systems aren't strong enough, these people may not respond well to live vaccines like the MMR. Achieving herd immunity, where at least 95% of the population is vaccinated, is very important. This kind of defence helps to protect people who can't get vaccinated themselves.

Measures to prevent infections

It is very important to implement good infection control measures to prevent the spread of measles, especially in healthcare settings. Quarantine and isolation can stop the spread of disease. Hospitals must strictly follow infection control rules, which include using personal protective equipment (PPE) and telling public health officials right away so they can find the source of the infection. To stop breakouts and protect vulnerable people, public health measures such as vaccinating people and providing accurate information are also very important.

Future directions and research

Progress in vaccinations

A major goal is to make vaccines safer for people who don't have strong immune systems. The main goal of current research is to develop non-live vaccines that can boost the immune system without harming the person. These improvements are meant to protect people who cannot receive live attenuated vaccines, such as the MMR, thereby lowering their risk of getting measles.

Better ways to treat the problem

To better treat measles in people who don't have strong immune systems, more research needs to be done on antiviral drugs and supportive treatments. Scientists are investigating new antiviral drugs, such as favipiravir, to see if they can reduce the severity and duration of measles symptoms. Additionally, improvements in supportive care, like better nutritional and immune system support, are crucial for improving patient outcomes. 

Policies for public health

It is important to strengthen public health strategies to better control measles in vulnerable groups. These strategies include getting more people vaccinated through targeted efforts, making it easier to handle outbreaks, and ensuring robust surveillance systems. By lowering the overall number of measles cases and ensuring that outbreaks are quickly contained, these measures aim to protect people who don't have strong immune systems.

FAQ’s

How does measles weaken the immune system?

Dendritic cells infected with MV are unable to initiate a mixed lymphocyte response; instead, they can make lymphocytes not respond by expressing MV glycoproteins. Therefore, more than one thing may both weaken the immune system during measles and build a strong immune system that lasts.1

Which group is more likely to have problems after getting measles?

Children under 5 years old and adults over 30 are most likely to experience complications. These complications occur more frequently in kids who aren't getting enough food, especially those who don't get enough vitamin A or those with weakened immune systems due to HIV or other diseases.2

In what ways does measles change a person's life?

Children under 5 years old are more likely to get very sick from measles. Ear infections and diarrhoea are common side effects. More serious side effects include asthma and encephalitis.3

Summary

It is very important to treat measles in immunocompromised people because they are more likely to get sick and face serious complications. Since measles is a very common virus, it puts these weak groups at great risk of getting pneumonia, encephalitis, and other potentially fatal conditions.

Some important points include how the MMR vaccine helps prevent measles and how difficult it is to vaccinate people who don't have strong immune systems. To protect these people, we need strong public health laws and effective ways to stop infections.

More research is needed to make vaccines safer and to improve antiviral treatments, which will lead to better care for people who don't have strong immune systems. To lessen the effects of measles, public health efforts need to be stepped up. This includes targeted vaccination programmes and better ways of handling outbreaks.

Overall, to protect immunocompromised people from the dangers of measles and improve their health outcomes, we need to use both cutting-edge medical research and proactive public health strategies.

References

Share

Pooja Singh

Masters of Pharmacy (M.Pharm.), Panjab University, Chandigarh (India)

Pooja is a seasoned pharmacovigilance professional with over a decade of experience in the drug safety domain within the pharmaceutical industry and service sectors. She has a comprehensive understanding of pharmacovigilance practices, from both operational and strategic perspectives and has demonstrated a deep commitment to ensuring the safety and efficacy of pharmaceutical products. With a Master of Pharmacy (M.Pharm) degree, her professional journey has been driven by a passion for pharmacovigilance and a dedication to improving public health outcomes.

Throughout her career, she has actively contributed to the development and maintenance of robust pharmacovigilance systems, adhering to global regulatory standards. Her expertise includes adverse event reporting, aggregate report writing, quality management, and signal detection, among other critical aspects of drug safety.

arrow-right